Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
BaseCAR-01 in B Cell Malignancies
NCT07166549Phase 1Not yet recruiting
- Sponsor
- University Hospital Basel
- Start
- Jun 2026
- Primary completion
- Nov 2028
- Countries
- 1
01
Overview
Phase 1, open-label, single-arm trial in B-cell malignancy, sponsored by University Hospital Basel. Primary endpoints: Adverse Events at 3 months, Cytokine Release Syndrome at 3 months and 2 more. Planned start Jun 2026; status: not yet recruiting.
02
Conditions
B-cell malignancy
Beyond the preview
Go deeper on NCT07166549.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07166549.